Flagship Ventures Fund IV General Partner LLC's Net Worth
$0
Who is Flagship Ventures Fund IV General Partner LLC?
Flagship Ventures Fund IV General Partner LLC does not have any significant net worth to report based on the numbers we have. This is based on reported shares across multiple companies, which include Moderna, Inc., Kaleido Biosciences, Inc., Seres Therapeutics, Inc., Editas Medicine, Inc., TransMedics Group, Inc., Rubius Therapeutics, Inc., Syros Pharmaceuticals, Inc., Eleven Biotherapeutics, Inc., T2 Biosystems, Inc., Axcella Health Inc., and Evelo Biosciences, Inc..
SEC CIK
Flagship Ventures Fund IV General Partner LLC's CIK is 0001508051
Past Insider Trading and Trends
Attention insiders: Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!
Moderna, Inc. (MRNA) Snapshot price: $72.23
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
| -36.29% | -11.05M |
—
|
—
| 19.41M |
Aug 17
| |||
Form 4
| -1.71% | -1.00M |
$68.22 | -$68,219,276.30 | 57.31M |
May 21 - May 22
| |||
Form 4
| -29.46% | -12.28M |
—
|
—
| 29.41M |
May 11
| |||
Form 4
| -5.75% | -9.67M |
$18.87 | -$8,196,935.61 | 158.57M |
Dec 9 - Dec 11
| |||
Form 4
|
∞
| 47.34M |
—
|
—
| 47.34M |
Dec 11
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
Kaleido Biosciences, Inc. (KLDO) Snapshot price: $0.0001
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
| +4.14% | 215K |
$11.50 | $2,472,500.00 | 5.41M |
Feb 8
| |||
Form 4
| +62.67% | 2M |
$7.50 | $15,000,000.00 | 5.19M |
Jun 4
| |||
Form 4
| +158.12% | 1.12M |
—
|
—
| 1.83M |
Mar 4
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
Seres Therapeutics, Inc. (MCRB) Snapshot price: $1
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
| -39.84% | -7.91M |
—
|
—
| 11.94M |
Nov 23
| |||
Form 4
| -12.02% | -2.00M |
$27.60 | -$27,600,000.00 | 14.64M |
May 25
| |||
Form 4
|
∞
| 11.63M |
—
|
—
| 11.63M |
Jun 25 - Jun 26
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
Editas Medicine, Inc. (EDIT) Snapshot price: $3.57
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
| -30.97% | -1.55M |
—
|
—
| 3.46M |
Aug 11
| |||
Form 4
|
∞
| 4.96M |
—
|
—
| 4.96M |
Feb 8
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
TransMedics Group, Inc. (TMDX) Snapshot price: $140
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
| -100.00% | -2.84M |
—
|
—
|
0
|
Oct 29
| |||
Form 4
| +49.67% | 839.7K |
—
|
—
| 2.53M |
May 6
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||